| Metric | Current Period | Prior-year period | YoY |
|---|---|---|---|
| Revenue | ¥38.5B | ¥41.4B | -6.8% |
| Operating Income | ¥0.1B | ¥-0.6B | - |
| Ordinary Income | ¥0.1B | ¥-0.6B | - |
| Net Income | ¥-0.2B | ¥-0.9B | - |
| ROE | -3.0% | -21.2% | - |
FY2026 Q3 results showed lower Revenue of ¥38.5B (YoY -¥2.9B, -6.8%) and improved Operating Income of ¥0.1B (turned positive from -¥0.6B in the prior year), but Net Income remained negative at -¥0.2B (prior year -¥0.9B, narrowing the loss by +¥0.7B). On the operating front, Operating Income turned positive due to SG&A control, but interest expense of ¥0.05B and Extraordinary Losses of ¥0.18B (including impairment of ¥15 million, etc.) weighed on Net Income. Total assets increased to ¥22.4B (YoY +¥2.5B, +12.6%), and Net Assets improved significantly to ¥6.7B (YoY +¥2.5B, +59.5%), while Cash and Deposits accumulated to ¥3.5B (YoY +¥1.8B, +96.8%). The full-year outlook expects Revenue of ¥518.0B (YoY -4.9%), Operating Income of ¥0.5B, and Net Income of ¥0.2B, projecting a return to the black.
[Profitability] Operating Margin 0.4% (improved by +1.8pt from -1.4% in the prior year; turned to operating profit), Gross Margin 15.6% (+0.4pt from 15.2% in the prior year), Net Margin -0.5% (improved by +1.6pt from -2.1% in the prior year; loss continued), ROE -3.0% (improved from -21.4% in the prior year, still below the company’s 3-year average), ROA -0.9% (improved from -4.5% in the prior year), ROIC 1.1%. [Cash Quality] Cash and Deposits ¥3.45B (2.0x prior year’s ¥1.70B), Short-term Debt Coverage 0.40x (Cash and Deposits / Current Liabilities ¥8.69B). [Investment Efficiency] Asset Turnover 1.72x (down from 2.08x in the prior year). [Financial Soundness] Equity Ratio 29.8% (improved by +8.9pt from 20.9% in the prior year), Current Ratio 89.8% (improved by +16.9pt from 72.9% in the prior year but still below 1.0x), Debt-to-Equity Ratio 2.36x (down from 3.78x in the prior year but still elevated), Interest Coverage 3.13x (EBIT ¥0.15B / Interest Expense ¥0.05B).
Cash and Deposits increased from ¥1.70B to ¥3.45B, up +¥1.75B (+103%), presumably supported by a turnaround to operating profit. On the balance sheet, Working Capital (Current Assets ¥7.80B - Current Liabilities ¥8.69B) is negative at -¥0.89B, but Accounts Receivable decreased to ¥3.05B (down -¥0.43B from ¥3.48B in the prior year), indicating improved collection. Accounts Payable slightly increased to ¥0.52B (up +¥0.04B from ¥0.48B), suggesting stable payment for purchases. Inventories increased to ¥0.29B (up +¥0.07B, +32% from ¥0.22B) but remain small in absolute terms. Property, Plant and Equipment decreased to ¥7.59B (down -¥0.15B from ¥7.74B), implying that impairments/depreciation exceeded investments. Non-current liabilities, mainly long-term borrowings, increased to ¥7.05B (up +¥0.42B from ¥6.63B), indicating cash accumulation through long-term financing. Short-term borrowings were ¥0.67B (slightly down from ¥0.69B), reflecting repayment of short-term debt. Cash coverage of short-term liabilities is 0.40x, and liquidity remains in the process of improvement.
Ordinary Income of ¥0.15B was nearly equal to Operating Income of ¥0.15B, indicating minimal non-operating impact, with interest expense of ¥0.05B roughly offset by interest and dividend income. Profit Before Tax was ¥0.01B, substantially compressed from Operating and Ordinary Income, mainly due to Extraordinary Losses of ¥0.18B (impairment loss of ¥0.15B and loss on sale of investment securities of ¥0.03B). Extraordinary losses were about 1.2x Operating Income, and one-off losses significantly pressured earnings. Income taxes were ¥0.21B, high relative to Profit Before Tax of ¥0.01B, resulting in an abnormal effective tax rate (distorted due to the small pre-tax profit). Consequently, Net Income was a loss of -¥0.20B. Non-operating income was not disclosed, but income from interest and dividends appears limited, and the bulk of income stems from core operations. The turnaround to operating profit is interpreted as the effect of SG&A restraint, but with a thin 0.4% margin, the quality of operating earnings is fragile. The combined impact of extraordinary losses and tax burden exceeded Operating Income; preventing recurrence of one-off losses and optimizing tax matters are necessary to generate sustainable profits.
Liquidity risk: The Current Ratio is 89.8%, below 1.0x, indicating issues with short-term payment capacity. Cash and Deposits of ¥3.45B versus Current Liabilities of ¥8.69B result in short-term debt coverage of only 0.40x. Working capital is negative, and short-term funding risk remains.
High leverage risk: The Debt-to-Equity Ratio is a high 2.36x, and the interest burden on total borrowings of ¥3.31B (short-term ¥0.67B + long-term ¥2.64B) is heavy. While Interest Coverage is 3.13x and not immediately dangerous, the Operating Margin is thin at 0.4%, so even a small operating deterioration could rapidly reduce interest payment capacity.
Fragile earning power: The Operating Margin of 0.4% significantly underperforms the industry median of 8.2%, with SG&A of ¥5.87B approaching Gross Profit of ¥6.03B. The earnings structure would swing to an operating loss with even a small decline in sales or gross margin deterioration. Asset impairment risks have materialized, creating uncertainty about asset recoverability.
[Position within the industry] (Reference information, our research) Profitability: The Operating Margin of 0.4% is far below the industry median of 8.2% (IQR 5.2%–10.9%), ranking at the bottom within the industry. The Net Margin of -0.5% is also significantly lower compared to the industry median of 5.7% (IQR 3.1%–9.1%). ROE -3.0% is far below the industry median of 9.7% (IQR 3.9%–15.0%), indicating inferior profitability within the industry. Sales growth of -6.8% contrasts with the industry median of +9.5% (IQR +2.7%–+15.2%), showing pronounced revenue decline. Soundness: The Equity Ratio of 29.8% is below the industry median of 49.0% (IQR 38.8%–66.3%), indicating below-average financial soundness. The Current Ratio of 89.8% is far below the industry median of 2.06x (IQR 1.53–2.95), marking one of the most challenging short-term liquidity positions in the industry. Efficiency: ROA of -0.9% is below the industry median of 4.7% (IQR 2.4%–8.1%), indicating inferior total asset efficiency within the industry. Overall: The company falls below the industry median across profitability, growth, and soundness, placing it at a low relative position within the industry. Notably, the gaps in Operating Margin and Current Ratio are large; rebuilding the earnings base and improving short-term liquidity are urgent priorities. Note: Industry: Healthcare (N=44), Comparison: FY2025 Q3 results, Source: Our compilation
Sustainability of the operating turnaround and cash accumulation: Operating Income turned positive YoY, but the margin remains at 0.4%, and Cash and Deposits increased by +¥1.75B. However, the Current Ratio is 89.8%, below 1.0x, and short-term liquidity risk remains unresolved. As Operating Cash Flow disclosure is unavailable, the cash backing of the operating profit is unclear; it is important to verify the sustainability of cash increase drivers (e.g., increased borrowings, receivables collection).
One-off nature of extraordinary losses and tax burden: Extraordinary Losses of ¥0.18B, including an impairment loss of ¥0.15B, were 1.2x Operating Income and the primary factor turning Net Income negative. Attention is warranted on the recurrence risk of such one-off losses and validation of asset soundness. Income taxes of ¥0.21B are high relative to Profit Before Tax of ¥0.01B, distorting the effective tax rate; details of deferred tax asset reversal and tax adjustments will be key for assessing financial transparency.
Hurdles to full-year profitability: The full-year forecast expects Operating Income of ¥0.5B and Net Income of ¥0.2B, returning to profit, but progress stands at 30% with Q3 Operating Income at ¥0.15B. A substantial improvement in Q4 is assumed; continued SG&A reduction and suppression of one-off losses are essential requirements.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not constitute a recommendation to invest in any specific security. The industry benchmarks are reference information compiled by our firm based on publicly available earnings data. Investment decisions are your own responsibility; consult a professional as needed before making any investment decisions.